Remission and progression-free survival in patients with newly diagnosed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone: Five-year follow-up of a phase 2 clinical trial Journal Article


Authors: Kazandjian, D.; Korde, N.; Mailankody, S.; Hill, E.; Figg, W. D.; Roschewski, M.; Landgren, O.
Article Title: Remission and progression-free survival in patients with newly diagnosed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone: Five-year follow-up of a phase 2 clinical trial
Journal Title: JAMA Oncology
Volume: 4
Issue: 12
ISSN: 2374-2437
Publisher: American Medical Association  
Date Published: 2018-12-01
Start Page: 1781
End Page: 1783
Language: English
DOI: 10.1001/jamaoncol.2018.5457
PROVIDER: scopus c2 - 30477009
PUBMED: 30477009
PMCID: PMC6440717
DOI/URL:
Notes: JAMA Oncol. -- Export Date: 2 January 2019 -- Letter -- Source: Scopus C2 - 30477009
Altmetric Score
MSK Authors
  1. Carl Ola Landgren
    198 Landgren
  2. Neha Sanat Korde
    64 Korde